Mary Beth Blauwet

Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart Failure

Kirkwood F. Adams, Stephanie H. Dunlap, Carla A. Sueta et al. · Journal of the American College of Cardiology · 1996 · 291 citations

Cardiomyopathy, Heart Failure, Cardiovascular Disease +8

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double‐blind, placebo‐controlled, phase <scp>III</scp> studies

V. Khullar, Philip E.V. van Kerrebroeck, Sender Herschorn et al. · International Journal of Clinical Practice · 2013 · 206 citations · Full text

Safety and tolerability of the β₃‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial

Christopher R. Chapple, C. Walters, Mary Beth Blauwet et al. · International Journal of Clinical Practice · 2014 · 83 citations · Full text

Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure.

Carla A. Sueta, S. W. Clarke, S Dunlap et al. · Circulation · 1994 · 70 citations · Full text

Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

Vik Khullar, J. Cambronero, J.C. Angulo et al. · BMC Urology · 2013 · 69 citations · Full text